A combination of the HER2 agent, called disitamab vedotin, and Junshi Biosciences’ PD-1 inhibitor toripalimab outperformed ...

Despite a risk for severe side effects, pembrolizumab has a record of improving recurrence-free survival that makes it an appealing treatment for advanced melanoma.

FDA grants accelerated approval to Verastem's Avmapki Fakzynja for KRAS-mutated ovarian cancer; company plans $75 million ...

Takeda was scrambling to accommodate for rapidly sinking profits from the hasty decline of ADHD mainstay Vyvanse with a 140 ...

CFO Kevin Moran reported Q1 2025 revenues of $50 million, a 5% increase year-over-year, attributed to Fanapt’s growth. Fanapt net product sales were $23.5 million, and HETLIOZ sales were $20.9 million ...

What are the best Fallout 4 mods on PC? Despite having been around for nearly a decade, Fallout 4 remains one of the most popular games in the series, thanks in no small part to its vibrant ...

Previously shared by FX Networks, that series of "transmission clips" from the USCSS Maginot that introduced us to some of the crew, an adorably smart cat, and some very interesting sights and ...

Mumbai: A major boost to Mumbai’s public transport infrastructure is on the horizon as Phase 2A of the underground Mumbai Metro Line 3, also known as Aqua Line, connecting Bandra-Kurla Complex ...

We’ve tested nearly three dozen PCIe 4.0 SSDs and our list includes the best of the bunch for various needs. Whether you want to upgrade, or add more storage to your PCIe 4.0 computer ...

LONDON, April 24 (Reuters) - The European Commission will in the next two weeks present a roadmap on how it intends to phase out all imports of Russian fossil fuels, its President Ursula von der ...

Kennedy Jr. has officially announced that, effective as of 4 PM EST today ... Makary announcing the U.S. government's intention to phase out the use of all petroleum-based synthetic dyes in ...

Sanofi said the Phase II miss was due to “the nature of this limited Phase II study”. Image credit: Shutterstock / LCV Sanofi will halt the development of its oral tumour necrosis factor (TNF) ...